MYCO 002
Alternative Names: MYCO-002Latest Information Update: 28 Nov 2021
At a glance
- Originator Mydecine Innovations Group
- Class Neuropsychotherapeutics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Mental disorders